Welcome back everyone! I hope you enjoyed your holiday and are looking forward to an exciting new year. My favorite thing about coming back from vacation is to see what cool new science was published. Because as you know, science doesn’t take a vacation! As I was reading over the news for this past week, … Continue reading While You Were Away: Gene Editing Treats Mice with Duchenne Muscular Dystrophy
Clinical Trials
CIRM’s clinical trial portfolio shows off stem cells’ many talents
When I first started working for California’s stem cell institute in 2008 I would never have guessed that we would be funding 15 clinical trials by the end of 2015. Medical science usually does not move that fast. But I, like most people back then, probably thought about stem cell science too narrowly, mostly as … Continue reading CIRM’s clinical trial portfolio shows off stem cells’ many talents
A New Vaccine Could Make Stem Cell Transplants Safer
Stem cell transplants offer a lot of promise for treating or curing patients who’ve exhausted their therapeutic options. However, there are some potential risks associated with putting stem cells into the human body such as cancer and infection. But scientists and clinicians are working hard to reduce the risk of stem cell therapies by testing … Continue reading A New Vaccine Could Make Stem Cell Transplants Safer
HIV/AIDS: Progress and Promise of Stem Cell Research
Our friends at Americans for Cures and Youreka Science have done it again. They’ve produced another whiteboard video about the progress and promise of stem cell research that’s so inspiring that it would probably make Darth Vader consider coming back to the light side. This time they tackled HIV. If you haven’t watched one of … Continue reading HIV/AIDS: Progress and Promise of Stem Cell Research
Board gives stem cell institute marching orders, and a road map
The poet T. S. Eliot once wrote: “If you aren't in over your head, how do you know how tall you are?” Well, everyone at CIRM, California’s stem cell institute, is about to find out how tall we are. Yesterday our governing Board approved a new Strategic Plan. To call it ambitious might be considered … Continue reading Board gives stem cell institute marching orders, and a road map
Doing nothing is not OK: A call for change at the FDA
The US Food and Drug Administration (FDA) is caught between a rock and a hard place. And CIRM is going to try and help them get out from under that. As things stand today, if the FDA approves a therapy quickly and a patient later dies from it, then they are widely criticized. If they … Continue reading Doing nothing is not OK: A call for change at the FDA
A step forward for Parkinson’s disease?
Imagine how frustrating it would be to not know whether you could physically sit through a dinner with friends or to worry about getting stuck in the grocery isle, fighting against a body that refuses to move. These nightmare-like experiences are what many Parkinson’s disease (PD) patients deal with on a daily basis. PD affects … Continue reading A step forward for Parkinson’s disease?
Type 1 Diabetes Trial Explained Whiteboard Video Style
There’s a saying, a picture is worth a thousand words. With complicated science however, pictures don’t always do these topics justice. Here’s where videos come to the rescue. Today’s topic is type 1 diabetes and a CIRM-funded clinical trial headed by the San Diego company ViaCyte hoping to develop a cure for patients with this disease. Instead of writing an entire … Continue reading Type 1 Diabetes Trial Explained Whiteboard Video Style
Eyeing Stem Cell Therapies for Vision Loss
Back by popular demand (well, at least a handful of you demanded it!) we’re pleased to present the third installment of our Stem Cells in Your Face video series. Episodes one and two set out to explain – in a light-hearted, engaging and clear way – the latest progress in CIRM-funded stem cell research related … Continue reading Eyeing Stem Cell Therapies for Vision Loss
Gene editing in blood stem cells just got easier
Genome editing is a field of science that’s been around for awhile, but has experienced an explosion of activity and interest in recent years. Chances are that even your grandmother has heard about the recent story where for the first time, gene editing saved a one-year-old girl from dying of leukemia. Microsoft word versus genome … Continue reading Gene editing in blood stem cells just got easier
The Stem Cellar 